How to buy SomaLogic stock (SomaLogic)

SomaLogic, a Boulder, Colorado-based biomarker discovery and clinical diagnostics company, is expected to go public via a merger with a special purpose acquisition company (SPAC). We'll update this page as new information becomes available.

Our top picks for where to buy Somalogic stock

Buy SomaLogic stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

SomaLogic stock price (NASDAQ: SLGC)

Use our graph to track the performance of SLGC stocks over time.

SomaLogic shares at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$1.93 - $2.74
50-day moving average more info button	$2.43
200-day moving average more info button	$2.45
Wall St. target price	$3.93
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.69

Is it a good time to buy SomaLogic stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

SomaLogic financials

Revenue TTM	$81.7 million
Gross profit TTM	$-11,271,000
Return on assets TTM	-14.17%
Return on equity TTM	-23.72%
Profit margin	-159.54%
Book value	$2.63
Market Capitalization more info button	$396.2 million

TTM: trailing 12 months

SomaLogic share dividends

We're not expecting SomaLogic to pay a dividend over the next 12 months.

You may also wish to consider:

• FMC Corporation (FMC.US) (4.49% forward annual dividend yield)

SomaLogic share price volatility

Over the last 12 months, SomaLogic's shares have ranged in value from as little as $1.93 up to $2.74. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SomaLogic's is 1.639. This would suggest that SomaLogic's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put SomaLogic's beta into context you can compare it against those of similar companies.

• Codexis (CDXS.US): 2.071
• FMC Corporation (FMC.US): 0.853

SomaLogic overview

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various biological samples for protein biomarker signatures, which are utilized in drug discovery and development. Its SomaScan's biomarker discoveries use in diagnostic applications for various diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal, a laboratory-developed test. It serves pharmaceutical and biotechnology companies, and academic and government research institutions.

Frequently asked questions

What percentage of SomaLogic is owned by insiders or institutions?
Currently 2.156% of SomaLogic shares are held by insiders and 61.713% by institutions. How many people work for SomaLogic?
Latest data suggests 451 work at SomaLogic. When does the fiscal year end for SomaLogic?
SomaLogic's fiscal year ends in December. Where is SomaLogic based?
SomaLogic's address is: 2945 Wilderness Place, Boulder, CO, United States, 80301 What is SomaLogic's ISIN number?
SomaLogic's international securities identification number is: US83444K1051